Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2463${count})

  • Research Grant, 2018
    Parkinson's Disease Progression Model

    Study Rationale:
    The rich and longitudinal (gathered over time) dataset available through the Parkinson's Progression Markers Initiative provides a unique opportunity to gain insights into the...

  • Target Advancement Program, 2018
    Role of 5-alpha Reductase 1 in the Therapy of Neurodegeneration and Levodopa-induced Dyskinesias

    Study Rationale:
    The two main types of the enzyme 5α-reductase (5αR) play a key role in the production of steroids in the brain and other organs. In pre-clinical testing, we found that inhibitors of...

  • Research Grant, 2018
    Using Deep Learning to Evaluate Changes Associated with Parkinson’s Disease

    Study Rationale:
    Recent advances in artificial intelligence and, in particular, in one of its methods called deep learning offer exciting opportunities for the diagnosis and treatment of Parkinson’s...

  • Research Grant, 2018
    Developing TLR2-Blocking Drugs to Reduce Alpha-synuclein-Induced Inflammation in Parkinson's Disease

    Promising Outcomes of Original Grant: 100 words)
    Synucleinopathies, including Parkinson's disease (PD), is a group of disorders affecting the central nervous system (CNS). These disorders share one key...

  • Research Grant, 2018
    Examining GCase Activity in People with REM Sleep Behavior Disorder

    Study Rationale:
    Approximately 80 percent of people with REM sleep behavior disorder (RBD) will develop a neurological disorder such as Parkinson's disease (PD). GBA mutations are the most frequent...

  • Research Grant, 2018
    Studying GBA Pseudogene as a Controller of GBA and Alpha-synuclein

    Study Rationale: 
    Mutations (changes) in the GBA gene are the most common genetic risk factor for Parkinson’s disease (PD). GBA has a clone called pseudogene, a similar stretch of DNA that, unlike the...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.